Issued Patents All Time
Showing 1–20 of 20 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12370176 | Methods of use for KV7 channel activators | Michael E. Bozik, Kelly Picchione, Gregory HEBRANK, Thomas Petzinger, Jr. | 2025-07-29 |
| 12138249 | Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils | Michael E. Bozik, Gregory HEBRANK, Wildon Farwell, Thomas Petzinger, Jr. | 2024-11-12 |
| 11612589 | Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils | Michael E. Bozik, Gregory HEBRANK, Wildon Farwell, Thomas Petzinger, Jr. | 2023-03-28 |
| 11026928 | Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils | Michael E. Bozik, Gregory HEBRANK, Wildon Farwell, Thomas Petzinger, Jr. | 2021-06-08 |
| 10980783 | Compositions and methods for treating conditions related to increased eosinophils | Michael E. Bozik, Gregory HEBRANK, Wildon Farwell, Thomas Petzinger, Jr. | 2021-04-20 |
| 10828284 | Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils | Michael E. Bozik, Gregory HEBRANK, Thomas Petzinger, Jr., Wildon Farwell | 2020-11-10 |
| 10456381 | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders | Michael E. Bozik | 2019-10-29 |
| 10383856 | Compositions and methods for treating conditions related to increased eosinophils | Michael E. Bozik, Gregory HEBRANK, Wildon Farwell, Thomas Petzinger, Jr. | 2019-08-20 |
| 10383857 | Compositions and methods for treating conditions related to elevated levels of eosinophils and/or basophils | Michael E. Bozik, Gregory HEBRANK, Thomas Petzinger, Jr., Wildon Farwell | 2019-08-20 |
| 10195183 | Compositions and methods for treating chronic urticaria | Michael E. Bozik | 2019-02-05 |
| 10028940 | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders | Michael E. Bozik | 2018-07-24 |
| 9763918 | Compositions and methods for treating chronic urticaria | Michael E. Bozik | 2017-09-19 |
| 9642840 | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders | Michael E. Bozik | 2017-05-09 |
| 9468630 | Compositions and methods for treating conditions related to increased eosinophils | Michael E. Bozik, Gregory HEBRANK, Wildon Farwell, Thomas Petzinger, Jr. | 2016-10-18 |
| 7041496 | DNA encoding rodent KCNQ2 potassium channel | Michael A. Blanar, Wen-Pin Yang, Paul C. Levesque, Valentin Gribkoff, Michael G. Neubauer +1 more | 2006-05-09 |
| 6893858 | Human kcnq5 potassium channel, methods and compositions thereof | Chandra Ramanathan, Joanne T. Trojnacki, Valentin Gribkoff | 2005-05-17 |
| 6855829 | 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease | Valentin Gribkoff, Gene Kinney, Piyasena Hewawasam | 2005-02-15 |
| 6831080 | Cinnamide derivatives as KCNQ potassium channel modulators | Yong-Jin Wu, Li-Quang Sun, Jie Chen, Huan He, Alexandre L'Heureux +4 more | 2004-12-14 |
| 6469042 | Fluoro oxindole derivatives as modulators if KCNQ potassium channels | Piyasena Hewawasam, Pierre Dextraze, Valentin Gribkoff, Gene Kinney | 2002-10-22 |
| 5621007 | Method for regulation of transmembrane chloride conductance | Valentin Gribkoff, Davis L. Temple, Jr. | 1997-04-15 |